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Abstract
A 33- year-old, Indonesian woman presented with pregnancy and glioblastoma. Chief complaint 
was headache that worsened since 1 month ago. Other complaints included vomitting,  seizure and 
weakness of the left part of her body when she was 12 weeks pregnant. CT scan result midline 
shift to the left of falx cerebri with obliterated right ventricle and hypodens mass on right region 
Craniotomy was performed but the patient refuse to terminate the pregnancy. Patient was supposed 
to undergo series of radiotherapy but decided not to since it may complicate her pregnancy. After 5 
month, patient had recurring complaint and CT scan showed  area of hypo and hyperdens in fronto-
parietal dextra and sinistra with brain edema. Joint operation of cesarean section continued with 
craniotomy was performed when her condition worsened. The patient treated in the intensive care 
unit and discharged home in good condition. Every brain tumours in pregnancy bring  dilemmas with 
no standard treatment in medicine. The treatment intention is  to minimise mortality and morbidity 
for both maternal and fetal. The management have to be individualised  from a multi-disciplinary 
team and the consideration of a multitude of factors, including location of the tumour, associated 
signs and symptoms, fetal gestation and the patient’s wishes.
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Glioblastoma dalam Kehamilan: Laporan Kasus
Abstrak
Seorang perempuan Indonesia berusia 33 tahun datang dengan kehamilan dan glioblastoma. 
Keluhan utamanya adalah  sakit kepala yang memberat 1 bulan yang lalu. Keluhan lain adalah 
muntah, kejang dan kelemahan dari bagian kiri tubuhnya ketika sedang hamil pada  usia kehamilan 
12 minggu. Hasil CT scan saat itu adalah pergeseran falx cerebri ke kiri dengan ventrikel kanan 
menghilang dan terdapat massa hypodens dengan. Kraniotomi dilakukan tanpa memperdulikan 
kehamilannya dan pasien menolak untuk mengakhiri kehamilan. Pasca-operasi pasien menolak 
menjalani radioterapi karena kehamilannya. Setelah 5 bulan, pasien menjalani CT scan kembali 
karena keluhannya berulang dan hasilnya adalah terdapat daerah hipo dan hiperdens di regio 
frontoparietal kanan dan kiri disertai dengan edema otak. Operasi bersama yaitu operasi sesar 
dilanjutkan dengan kraniotomi dilakukan karena keadaan pasien yang memburuk. Pasien kemudian 
dirawat di unit perawatan intensif pasca-operasi dan pulang dalam kondisi baik. Setiap tumor di 
otak dalam kehamilan membawa dilema tanpa adanya standar pengobatan. Tujuan pengobatan 
adalah meminimalkan mortalitas dan morbiditas untuk ibu dan janin. Tatalaksana harus dibuat 
secara individual oleh tim secara multi-disiplin dengan pertimbangan berbagai faktor termasuk 
lokasi tumor, tanda dan gejala terkait, usia kehamilan dan keinginan pasien tersebut.
Kata kunci:  glioblastoma, kehamilan, kanker
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Introduction
The incidence of primary intracranial tumour 
in pregnancy is only 0.36 per 100.000 births.1 As 
woman in developed societies defer childbearing to 
the third or fourth decade of life, this rare association 
is likely to become more common.2 Although 
considered as the most common intracranial 
tumour, glioblastoma multifome has an incidence 
of only 1 in 33.330 in the general population and 
carry prognosis of approximately 14 months.3 
Glioblastomas are a heterogeneous group of 
neoplasms that comprise the majority of tumors 
originating in the central nervous system (CNS).4 
Although there are no increased incidence of brain 
tumors in pregnancy, the initial manifestation, 
especially gliomas, has been found to occur during 
the first trimester.4 It has been noted that pregnancy 
often masks the presence of an intracranial 
neoplasm and that the risk of misdiagnosis is high. 
This is because symptoms such as headache, 
vomiting, visual disturbance are often encountered 
in pregnancy. Here we present the case report of 
a recurrent glioblastoma multiforme in pregnancy.
Case Presentation
History, Examination and Management
A 33- year-old, gravida 2 para 1, Indonesian 
Acehnese woman presented with pregnancy and 
recurrent glioblastoma. Her chief complaint was 
headache that is worsening since 1 month ago. 
She is a patient of neurosurgery department since 7 
months earlier with complaints of major headache, 
vomitting,  seizure and weakness of the left part 
of her body when she was 12 weeks pregnant. 
Patients was diagnosed with brain tumor on right 
temporoparietal region. Her CT scan result were 
midline shift to the left of falx cerebri with obliterated 
right ventricle and hypodens mass on right region 
size 5,04x 5,17 cm x 5,79 cm. (Fig 1)
Craniotomy was performed with no regards of 
the pregnancy but the patient refuse to terminate the 
pregnancy. Post craniotomy patient was supposed 
to undergo series of radiotherapy but decided not to 
      Figure 1. CT Scan Result before the First    
                      Operation
since it may complicate her pregnancy. After 5 month 
went untreated, patient then had another CT scan due 
to her recurring complaint and the result was there’s 
an area of hypo and hyperdens in frontoparietal 
dextra and sinistra with brain edema (Figure 2).  
Figure 2.  CT Scan Result when The Glioblastoma 
is Recurring (A) Compared to The Post 
op Result (B)
The patient was treated for a week when her 
condition was worsening with loss of consciousness. 
Joint operation with neurosurgery department was 
performed, consist of cesarean section that was 
continued with craniotomy. We delivered a healthy 
1900 gram baby boy. The patient was then treated for 
2 days in the intensive care unit and another 4 days 
in the ward then discharged home in good condition. 
Discussion
In 2009, the American Cancer Society estimated 
that one in four deaths in the United States was due to 
cancer and that cancer was the second most common 
cause of death during reproductive years.5 As woman 
tend to delay childbearing to the third decade of 
life, the incidence of gestational cancer is expected 
to increase.5 Of the 18,820 new cases of primary 
central nervous system tumors diagnosed annually 
in the United States, gliomas account for over 60% 
with 30-40% of them being glioblastoma multiforme, 
10% being anaplastic astrocytoma and 10% being 
low grade gliomas.4  The most common malignancies 
associated with pregnancy are reported to be breast 
cancer, cervical cancer, melanoma, thyroid and 
hodgkin’s lymphoma with less frequent malignancies 
are leukemia, ovarian, lung and gastrointestinal 
cancers.5 An alternative explanation for the reduced 
occurrence of primary intracranial neoplasms in 
pregnant patients may lie not in the patterns of 
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tumour growth but in reduced fertility of patients with 
preclinical or undiagnosed brain tumours.6 
The concurrence of a brain tumour and 
pregnancy constitutes a clinical problem with 
symptoms such as headache, vomiting and visual 
disturbance where it is  common to both brain 
tumours and pregnancy and convulsions caused 
by a brain tumour may falsely considered due to 
eclampsia.7 Common presenting symptoms include 
generalised symptoms such as headache, nausea 
and vomiting, seizures, syncope and cognitive 
dysfunction. Common focal symptoms include 
visual, language, motor and sensory disturbances.8-9 
Our patient had recurring symptoms of of major 
headache and vomitting. Since it was early in the 
pregnancy, a lot of medical doctor that she had 
visited thought of it as only minor clinical pregnancy 
complaints. When she complaints of seizure and 
weakness of the left part of her body, that was when 
her doctor realized it and have it checked.  Her CT 
scan result are midline shift to the left of falx cerebri 
with obliterated right ventricle and hypodens mass 
on right region size 5,04x 5,17 cm x 5,79 cm.
It has been shown that pregnancy predisposes 
the brain to edema formation by upregulation of a type 
of channel forming trans-membrane protein called 
aquaporin-4 .This protein facilitates the movement 
of water, glycerol and other solutes across plasma 
membrane. The likelihood of blood-brain barrier 
disruption in the presence of neoplasm, further 
increases the likelihood of edema formation and 
could become worsened if eclampsia is present.5 
Others thought that  pregnancy does not increase 
the growth rate of tumour cells and enlargement 
of tumour size is considered to be a consequence 
of engorgement of the blood vessels which feed 
the tumour or to a state of positive water balance 
as a result of the altered hormonal environment 
accompanying pregnancy.7  In some tumours, such 
as meningioma, pituitary adenomas and angiomas, 
however, estrogen and/or progesterone induced 
proliferation of tumour cells during pregnancy.7
Several theories have been advanced to 
account for the exacerbation of brain tumor-
related maternal symptoms that may occur during 
pregnancy, including steroid hormone-mediated 
growth (meningiomas) and hemodynamic changes 
(increased systemic and cerebral blood volume). 
A potential mechanism that could result in clinical 
deterioration in expectant mothers with malignant 
gliomas is an increase in intracranial mass effect 
from increased tumor blood volume caused by 
hemodynamic changes inherent to pregnancy.10
When considering termination of pregnancy, 
qualified and teamed medical personnel should 
inform patients about the risks for their health and for 
the fetus from anti-neoplastic therapy administered 
during pregnancy.5   The management is complicated 
by the need to consider induced abortion, mode of 
delivery, neurosurgical management, and adjuvant 
treatment including radiation therapy to the mother.7
Management should be individualised depend 
on the patient’s symptoms and signs, the nature and 
site of the tumour and the stage of pregnancy. In stable 
patients with non-life threatening tumours, such as 
benign supratentorial tumours without any evidence 
of increased intracranial pressure, management 
should be based on obstetric criteria.7 In patients 
whose condition rapidly deteriorates, or in whom the 
brain tumour is malignant, the management  should 
be different from that of patients in a stable condition. 
Definitive tumour treatment may be required before 
delivery and, in the worst case, pregnancy may not 
be allowed to continue.7 
There are no guidelines for the adjuvant 
administration of chemotherapy or radiotherapy 
or the ideal timing of neurosurgical or obstetrical 
intervention in pregnant women.10 Because of 
the relative paucity of reported cases of gliomas 
diagnosed and treated during pregnancy, the 
literature right now comprises only case reports and 
small series.10 The treatment of malignant gliomas 
requires a multidisciplinary approach. Current 
standards of practice for treating newly diagnosed 
high-grade glioma include maximal safe resection 
followed by radiotherapy, and, in the instance of newly 
diagnosed glioblastoma, adjuvant chemotherapy.10
A patient who presents during the first or 
early second trimesters may be considered for 
neurosurgery as the fetus is remote from viability. 
Radiotherapy, radiosurgery and image-guided 
surgery may also be an option after the fi rst 
trimester. Benefits of anti-epileptic medications to 
control maternal symptoms outweigh their risks of 
teratogenicity and should not be withheld.8
Increased intracranial pressure can occur from 
the added effects of pressure from the exertions of 
labor upon the tumor and associated peritumoral 
edema.  This scenario is more of a concern in an 
undiagnosed,untreated patient. In the case of a 
symptomatic tumor,an elective Caesarean section 
should be encouraged.10 Major operations can 
be safely performed throughout gestation without 
increased maternal risk, but a 1–3% risk of foetal 
loss and aminimally increased relative risk (1.5–2.0) 
for low birth weight and premature delivery exits. 2
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After the first operation, the patient was 
supposed  to underwent radiation with abdominal 
shielding. But the patient refused to do so. And after 
5 month went untreated, patient then had another CT 
scan due to her recurring complaint and the result 
was there’s an area of hypo and hyperdens in fronto 
parietal dextra and sinistra with brain edema.  The 
patient was treated for a week when her condition 
was worsening with loss of consciousness when we 
finally decided to perform joint operation cesarean 
section and continued with craniotomy.
The usage of radiation  effect differ correlate 
to  gestation age. During the pre-implantation and 
implantation period  the ‘‘all or nothing’’ rule applies 
where irradiation of the undifferentiated embryo 
results in either death or normal development and 
doses as low as 100 mGy can cause embryonic 
death, with a reported incidence of 50% with 
doses of 1 Gy. During the period of organogenesis 
(weeks 3–12), embryonic death or developmental 
malformations are frequent with radiation doses of 
1 Gy and may occur with doses as low as 50–250 
mGy. The foetal dose of 100 mGy (10 rad) during 
the first trimester is frequently cited as a ‘‘threshold 
dose’’ for the risk of teratogenesis. Exposure to 250 
mGy or higher doses of ionizing radiation during 
the second and third trimesters is associated 
with growth retardation, mental retardation, 
malformations of late-forming tissues (central 
nervous system, gonads) and premature birth.2
It is well known that therapeutic irradiation of 
pregnant women can cause microcephaly, mental 
retardation or even foetal death, especially during the 
first trimester, or when the pelvis is included within 
the primary radiation field. When the cranial radiation 
dose is 40 Gy, the estimated total foetal dose received 
during the entire course of radiation is approximately 
8 Gy.7 The risk of cancer up to the age of 15 years 
attributable to radiation is 1 in 1700 per cGy, of which 
half will be fatal (i.e. 1 in 3300 per cGy). A dose of 2.2 
cGy adds a risk of fatal cancer by the age 15 years of 
only 1 in 1500. Because the addition of shielding might 
halve the fetal dose, this risk should be reduced to 1 in 
3000.11 For the fetus, these detrimental effects include 
congenital malformations, potential carcinogenesis, 
organ toxicity, prematurity, impaired fetal weight gain, 
growth retardation, and developmental delay. For the 
mother, chemotherapy associated risks include stillbirth, 
spontaneous abortion, and maternal sterility. 10
Conclusion
Every brain tumours in pregnancy bring dilemmas 
with no standard treatment in medicine.  Its diagnosis 
is challenging because of the need to treat the mother 
and minimizing the effects of cancer treatment on the 
fetus. The treatment intention is  to minimise mortality 
and morbidity for both maternal and fetal which 
can be achieved by prolonging pregnancy while 
alleviating complications from the brain tumour. The 
management have to be individualised from a multi-
disciplinary team and the consideration of a multitude 
of factors, including nature and location of the tumor, 
associated signs and symptoms, fetal gestation and 
the patient’s wishes.
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